| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $377K | +249.1% |
| Cost of Revenue | $198K | +178.9% |
| Gross Profit | $179K | +383.8% |
| R&D Expense | $104K | -33.8% |
| SG&A Expense | $1.3M | +41.5% |
| Operating Income | -$1.2M | -17.7% |
| Pre-tax Income | -$985K | +0.0% |
| Net Income | -$1.2M | -26.0% |
| EPS (Basic) | -$0.57 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $750K | -40.3% |
| Accounts Receivable | $41K | +10.8% |
| Current Assets | $907K | -33.1% |
| Total Assets | $1.2M | -23.2% |
| Current Liabilities | $756K | +119.1% |
| Total Liabilities | $1.1M | +48.1% |
| Stockholders' Equity | $100K | -88.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$811K | +11.7% |
| Capital Expenditures | $205K | +166.2% |
| Investing Cash Flow | -$205K | -166.2% |
| Financing Cash Flow | $475K | — |
| Free Cash Flow | -$1.0M | -2.1% |
| -2750.0% |
| EPS (Diluted) | -$0.57 | -2750.0% |